I am Kirill Didenko, a pharmaceutical scientist, CEO of a novel AI laboratory - Didenko Technologies - at the intersection of pharmaceuticals and artificial intelligence.Our team has developed Didenectin, a promising medicine targeting Dengue. In preclinical research, Didenectin demonstrated significant effectiveness in reducing the viral load of Dengue by 93% during the 24h in vivo, leading to revolutionary rapid recovery of Dengue patients within a record 24-48 hour timeframe.At Didenko Technologies, our approach is fueled by state-of-the-art AI algorithms that accelerate the drug research process, paving the way for faster, more effective treatments.